These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


439 related items for PubMed ID: 19195631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L.
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [Abstract] [Full Text] [Related]

  • 4. The role of FXR in disorders of bile acid homeostasis.
    Eloranta JJ, Kullak-Ublick GA.
    Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B.
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [Abstract] [Full Text] [Related]

  • 7. FXR: a promising target for the metabolic syndrome?
    Cariou B, Staels B.
    Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FXR: a metabolic regulator and cell protector.
    Wang YD, Chen WD, Moore DD, Huang W.
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [Abstract] [Full Text] [Related]

  • 10. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P, Hierro L, Jara P, Alvarez L.
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W.
    Cancer Res; 2007 Feb 01; 67(3):863-7. PubMed ID: 17283114
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T, Staels B, Kuipers F.
    Arterioscler Thromb Vasc Biol; 2005 Oct 01; 25(10):2020-30. PubMed ID: 16037564
    [Abstract] [Full Text] [Related]

  • 14. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
    Swales KE, Korbonits M, Carpenter R, Walsh DT, Warner TD, Bishop-Bailey D.
    Cancer Res; 2006 Oct 15; 66(20):10120-6. PubMed ID: 17047076
    [Abstract] [Full Text] [Related]

  • 15. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
    Martin IV, Schmitt J, Minkenberg A, Mertens JC, Stieger B, Mullhaupt B, Geier A.
    Biol Chem; 2010 Dec 15; 391(12):1441-9. PubMed ID: 20868235
    [Abstract] [Full Text] [Related]

  • 16. Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.
    Zhang S, Liu Q, Wang J, Harnish DC.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):476-9. PubMed ID: 19118524
    [Abstract] [Full Text] [Related]

  • 17. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ, Mahaney PE, Borges-Marcucci L, Lai K, Wang S, Krueger JA, Gardell SJ, Huard C, Martinez R, Vlasuk GP, Harnish DC.
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar 06; 296(3):G543-52. PubMed ID: 19136377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A, Renga B, Migliorati M, Cipriani S, Distrutti E, Santucci L, Fiorucci S.
    J Immunol; 2009 Nov 15; 183(10):6657-66. PubMed ID: 19880446
    [Abstract] [Full Text] [Related]

  • 20. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
    Duran-Sandoval D, Cariou B, Fruchart JC, Staels B.
    Biochimie; 2005 Jan 15; 87(1):93-8. PubMed ID: 15733743
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.